News
The National Institute for Health and Care Excellence (NICE) has maintained its decision not to recommend two treatments for Alzheimer’s disease on the NHS, after concluding that they still do not ...
The Alzheimer’s Association has launched a new, free app to help those in the early stages of the disease and their loved ...
NICE has once again rejected new drugs for early Alzheimer’s disease because the costs are too great to justify the small ...
While many are aware of memory problems as a sign of dementia, there's another early symptom of the disease to be mindful of.
However, in both cases, NICE immediately published draft guidance that concluded the anti-amyloid drugs were too expensive to ...
The benefits of Alzheimer’s treatments donanemab and lecanemab remain too small to justify the additional costs ...
Two drugs to treat Alzheimer’s disease have been rejected for use on the NHS because their benefits are “too small” to ...
Explore key strategies for managing dementia confusion and Alzheimer’s. Learn about recognizing signs, using the Confusion Assessment Method, and adapting daily routines for better care of affected in ...
Galpin said his mother’s general demeanor improved, and as a former cheerleader, she gets particularly excited when local cheerleaders stop by.
Alzheimer's is becoming more and more common across the U.S. According to the Alzheimer's Association, more than 7 million Americans are living with the disease ...
June is brain and Alzheimer’s Disease Awareness Month, a time to focus on our brains’ health. As we age, memory lapses and ...
According to the Alzheimer’s Association, over 7 million Americans are living with Alzheimer’s disease in 2025, and that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results